Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Prescription Gastrointestinal Drugs market report explains the definition, types, applications, major countries, and major players of the Prescription Gastrointestinal Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
AstraZeneca
Merck
Salix Pharmaceuticals
GlaxoSmithKline
Eisai
Axcan Pharmaceuticals
By Type:
Oral
Topical
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Prescription Gastrointestinal Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Prescription Gastrointestinal Drugs Outlook to 2028- Original Forecasts
-
2.2 Prescription Gastrointestinal Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Prescription Gastrointestinal Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Prescription Gastrointestinal Drugs Market- Recent Developments
-
6.1 Prescription Gastrointestinal Drugs Market News and Developments
-
6.2 Prescription Gastrointestinal Drugs Market Deals Landscape
7 Prescription Gastrointestinal Drugs Raw Materials and Cost Structure Analysis
-
7.1 Prescription Gastrointestinal Drugs Key Raw Materials
-
7.2 Prescription Gastrointestinal Drugs Price Trend of Key Raw Materials
-
7.3 Prescription Gastrointestinal Drugs Key Suppliers of Raw Materials
-
7.4 Prescription Gastrointestinal Drugs Market Concentration Rate of Raw Materials
-
7.5 Prescription Gastrointestinal Drugs Cost Structure Analysis
-
7.5.1 Prescription Gastrointestinal Drugs Raw Materials Analysis
-
7.5.2 Prescription Gastrointestinal Drugs Labor Cost Analysis
-
7.5.3 Prescription Gastrointestinal Drugs Manufacturing Expenses Analysis
8 Global Prescription Gastrointestinal Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Prescription Gastrointestinal Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Prescription Gastrointestinal Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Prescription Gastrointestinal Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Prescription Gastrointestinal Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2 Global Prescription Gastrointestinal Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Prescription Gastrointestinal Drugs Market Analysis and Outlook till 2022
-
10.1 Global Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.2.2 Canada Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.2.3 Mexico Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.2 UK Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.3 Spain Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.4 Belgium Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.5 France Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.6 Italy Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.7 Denmark Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.8 Finland Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.9 Norway Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.10 Sweden Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.11 Poland Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.12 Russia Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.3.13 Turkey Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.2 Japan Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.3 India Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.4 South Korea Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.8 Thailand Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.9 Singapore Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.11 Philippines Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.2 Colombia Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.3 Chile Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.4 Argentina Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.6 Peru Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.6.3 Oman Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.6.4 Qatar Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.7.2 South Africa Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.7.3 Egypt Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.7.4 Algeria Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Prescription Gastrointestinal Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Prescription Gastrointestinal Drugs Consumption (2017-2022)
11 Global Prescription Gastrointestinal Drugs Competitive Analysis
-
11.1 AstraZeneca
-
11.1.1 AstraZeneca Company Details
-
11.1.2 AstraZeneca Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 AstraZeneca Prescription Gastrointestinal Drugs Main Business and Markets Served
-
11.1.4 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Merck
-
11.2.1 Merck Company Details
-
11.2.2 Merck Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Merck Prescription Gastrointestinal Drugs Main Business and Markets Served
-
11.2.4 Merck Prescription Gastrointestinal Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Salix Pharmaceuticals
-
11.3.1 Salix Pharmaceuticals Company Details
-
11.3.2 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Main Business and Markets Served
-
11.3.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 GlaxoSmithKline
-
11.4.1 GlaxoSmithKline Company Details
-
11.4.2 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Main Business and Markets Served
-
11.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Eisai
-
11.5.1 Eisai Company Details
-
11.5.2 Eisai Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Eisai Prescription Gastrointestinal Drugs Main Business and Markets Served
-
11.5.4 Eisai Prescription Gastrointestinal Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Axcan Pharmaceuticals
-
11.6.1 Axcan Pharmaceuticals Company Details
-
11.6.2 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Main Business and Markets Served
-
11.6.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
12 Global Prescription Gastrointestinal Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Prescription Gastrointestinal Drugs Market Analysis and Outlook to 2028
-
13.1 Global Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Prescription Gastrointestinal Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Prescription Gastrointestinal Drugs
-
Figure of Prescription Gastrointestinal Drugs Picture
-
Table Global Prescription Gastrointestinal Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Prescription Gastrointestinal Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Table North America Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure United States Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure Germany Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure China Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure Brazil Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Prescription Gastrointestinal Drugs Consumption by Country (2017-2022)
-
Figure Australia Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Prescription Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)
-
Table AstraZeneca Company Details
-
Table AstraZeneca Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Prescription Gastrointestinal Drugs Main Business and Markets Served
-
Table AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
-
Table Merck Company Details
-
Table Merck Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Prescription Gastrointestinal Drugs Main Business and Markets Served
-
Table Merck Prescription Gastrointestinal Drugs Product Portfolio
-
Table Salix Pharmaceuticals Company Details
-
Table Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Prescription Gastrointestinal Drugs Main Business and Markets Served
-
Table Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Prescription Gastrointestinal Drugs Main Business and Markets Served
-
Table GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
-
Table Eisai Company Details
-
Table Eisai Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Prescription Gastrointestinal Drugs Main Business and Markets Served
-
Table Eisai Prescription Gastrointestinal Drugs Product Portfolio
-
Table Axcan Pharmaceuticals Company Details
-
Table Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Main Business and Markets Served
-
Table Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Prescription Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Prescription Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)
-
